Schedule 13G ownership disclosure

AERIE PHARMACEUTICALS INC

Security class unavailable · CUSIP: 00771V108

Event date: 2017-06-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,885,075
Percent of class
5.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000053417-17-000126
Form type
SC 13G/A
Filer
AERIE PHARMACEUTICALS INC
CIK
CIK 1337553
Filed
Jul 10, 2017
Reporting period
Jun 30, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub